Lucid Diagnostics Inc. entered into a securities purchase agreement for the sale of a Senior Secured Convertible Note in initial principal amount of up to $11,111,110 in a private placement. The company also entered into a registration rights agreement and a voting agreement with its parent company PAVmed Inc.